Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
97903515 | 9790351 | 5 | F | 20111226 | 20160822 | 20131231 | 20160825 | EXP | CO-ABBVIE-13P-036-1184176-00 | ABBVIE | 54.67 | YR | F | Y | 60.00000 | KG | 20160825 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
97903515 | 9790351 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | U | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
97903515 | 9790351 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | U | UNKNOWN | 125057 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
97903515 | 9790351 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | U | UNKNOWN | 125057 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
97903515 | 9790351 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | U | UNKNOWN | 125057 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
97903515 | 9790351 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
97903515 | 9790351 | 6 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
97903515 | 9790351 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
97903515 | 9790351 | 8 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | ||||||||||||
97903515 | 9790351 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | 100 | UG | TABLET | QD | ||||||||
97903515 | 9790351 | 10 | C | CYCLOSPORINE. | CYCLOSPORINE | 1 | 0 | ||||||||||||
97903515 | 9790351 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 1 CAPSULE FASTED | 0 | CAPSULE | ||||||||||
97903515 | 9790351 | 12 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | 0 | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
97903515 | 9790351 | 1 | Rheumatoid arthritis |
97903515 | 9790351 | 5 | Product used for unknown indication |
97903515 | 9790351 | 6 | Product used for unknown indication |
97903515 | 9790351 | 7 | Product used for unknown indication |
97903515 | 9790351 | 8 | Product used for unknown indication |
97903515 | 9790351 | 9 | Product used for unknown indication |
97903515 | 9790351 | 10 | Product used for unknown indication |
97903515 | 9790351 | 11 | Product used for unknown indication |
97903515 | 9790351 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
97903515 | 9790351 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
97903515 | 9790351 | Arthritis | |
97903515 | 9790351 | Elbow deformity | |
97903515 | 9790351 | Erythema | |
97903515 | 9790351 | Inflammation | |
97903515 | 9790351 | Joint range of motion decreased | |
97903515 | 9790351 | Osteoarthritis | |
97903515 | 9790351 | Pain | |
97903515 | 9790351 | Post procedural complication | |
97903515 | 9790351 | Postoperative wound infection | |
97903515 | 9790351 | Procedural pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
97903515 | 9790351 | 1 | 20100730 | 20131214 | 0 | |
97903515 | 9790351 | 2 | 20150305 | 0 | ||
97903515 | 9790351 | 3 | 20160405 | 0 | ||
97903515 | 9790351 | 4 | 20160714 | 0 |